Breast Cancer Clinical Trial
Official title:
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
This study will explore provider's screening and management practices for eligibility for neoadjuvant therapy from baseline to following the project intervention (use of a novel existing technology, the Carevive Care Planning System at the point of care plus provider continuing medical education.
The overarching goals are to improve clinician knowledge about evidence-based practices for
neoadjuvant therapy for breast cancer, increase appropriate referrals to medical oncology for
consideration of preoperative systemic therapy (as determined by adherence to NCCN
pre-operative systemic therapy guidelines), and to improve communication between the
multidisciplinary team and patient regarding the appropriateness, selection, and timing of
neoadjuvant therapy. Secondary objectives include a) evaluation of the impact of the
intervention on actual prescription of neoadjuvant therapy to eligible patients and b)
evaluation of the impact of the intervention on surgeons and medical oncologists' knowledge,
attitudes, and beliefs about the benefits of neoadjuvant therapy. We will also explore the
acceptability and utilization of the Carevive care plan during medical oncologists' initial
consultations after referral of patients from surgical practices. In this project, 25 newly
diagnosed breast cancer patients will be recruited over a 3-6 month period, screened for
eligibility for neoadjuvant therapy, and assessed for patient treatment preferences at time
of surgical consultation using a novel and commercially available electronic technology, the
Carevive Care Planning System (CPS). Patients will receive a care plan that explains
neoadjuvant therapy among possible treatment options. In addition, patients will be screened
for distress as well as eligibility for genetic counseling (according to NCCN referral
criteria) and fertility preservation (according to ASCO guidelines) referrals, and the
Carevive care plans provided will also incorporate personalized referrals to these related
services where applicable.
Retrospective chart reviews (from both surgical and medical oncology practices participating
in this project), complemented by data extracted from the Carevive CPS, will be used to
assess changes in rates of referrals to medical oncology for discussion and actual
prescriptions of neoadjuvant therapy, as compared to historical data from prior publications
documenting low rates of referral to, and receipt of, neoadjuvant therapy. Provider
questionnaires exploring knowledge, attitudes, and beliefs about the benefits of neoadjuvant
therapy will be completed at baseline and again at follow-up (≤4 weeks following intervention
visit of their last patient) and changes will be explored using a pre-/post-test design. Use
of a care planning technology to provide tailored education and individualized information
may provide an easy, accessible and effective way to improve provider abilities to
proactively identify patients eligible for specific therapies, understand patient treatment
goals, concerns, drive shared decision making (SDM) and sufficiently collaborate with the
multi-disciplinary team to provide optimal care.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Recruiting |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |